制药公司Esperion Therapeutics的股票被多家券商下调至“持有”。 Pharmaceutical company Esperion Therapeutics' stock downgraded to 'hold' by multiple brokerages.

制药公司Esperion Therapeutics的股票已被包括 StockNews.com 和美国银行在内的多家券商下调，平均评级目前为“持有”。 Pharmaceutical company Esperion Therapeutics has seen its stock downgraded by multiple brokerages, including StockNews.com and Bank of America, with the average rating now at 'hold'. 该公司侧重于开发高胆固醇的治疗方法,并商定目标价格为8.17美元。 The company focuses on developing treatments for high cholesterol and has a consensus target price of $8.17. 公司的股票开盘价为1.96美元,市值为3.713亿美元. Its stock, ESPR, opened at $1.96 with a market cap of $371.34 million. 机构投资者持有公司股票的47.39%。 Institutional investors hold 47.39% of the company's stock.